• Kintara Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement

    2 monthes ago - By San Diego Biotechnology

    SAN DIEGO, June 3, 2022 /PRNewswire/ - Kintara Therapeutics, Inc. , a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that the Company received...
    Read more ...

     

  • Sr. Research Associate/Research Associate - Sorrento Therapeutics, Inc. - San Diego, CA

    2 monthes ago - By San Diego Biotechnology

    Sorrento Therapeutics, Inc. is a federal government contractor and, in compliance with its obligations under current federal regulations, Sorrento requires...
    Read more ...